Log in

NASDAQ:NEPTNeptune Wellness Solutions Stock Price, Forecast & News

$3.15
+0.15 (+5.00 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.00
Now: $3.15
$3.19
50-Day Range
$1.87
MA: $2.41
$3.09
52-Week Range
$0.96
Now: $3.15
$6.57
Volume700,484 shs
Average Volume1.28 million shs
Market Capitalization$299.44 million
P/E RatioN/A
Dividend YieldN/A
Beta2.72
Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.11 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NEPT
CUSIPN/A
Phone45-0687-2262

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.39 million
Book Value$0.66 per share

Profitability

Net Income$-17,670,000.00
Net Margins-132.09%

Miscellaneous

Employees58
Market Cap$299.44 million
Next Earnings Date6/10/2020 (Estimated)
OptionableOptionable

Receive NEPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter.

Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions

How has Neptune Wellness Solutions' stock been impacted by COVID-19 (Coronavirus)?

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NEPT stock has increased by 160.3% and is now trading at $3.15. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Neptune Wellness Solutions?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neptune Wellness Solutions.

When is Neptune Wellness Solutions' next earnings date?

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Wednesday, June 10th 2020. View our earnings forecast for Neptune Wellness Solutions.

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) announced its quarterly earnings data on Wednesday, October, 12th. The biotechnology company reported ($0.02) earnings per share for the quarter. The biotechnology company earned $8.91 million during the quarter. Neptune Wellness Solutions had a negative net margin of 132.09% and a negative return on equity of 39.22%. View Neptune Wellness Solutions' earnings history.

What guidance has Neptune Wellness Solutions issued on next quarter's earnings?

Neptune Wellness Solutions updated its first quarter 2021 IntraDay earnings guidance on Thursday, May, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18-22 million.

What price target have analysts set for NEPT?

3 brokers have issued 1 year target prices for Neptune Wellness Solutions' stock. Their forecasts range from $3.75 to $3.75. On average, they expect Neptune Wellness Solutions' stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price. View analysts' price targets for Neptune Wellness Solutions.

Has Neptune Wellness Solutions been receiving favorable news coverage?

News headlines about NEPT stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neptune Wellness Solutions earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutNeptune Wellness Solutions.

Are investors shorting Neptune Wellness Solutions?

Neptune Wellness Solutions saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,430,000 shares, an increase of 14.1% from the April 30th total of 7,390,000 shares. Based on an average daily trading volume, of 1,310,000 shares, the days-to-cover ratio is presently 6.4 days. Approximately 11.0% of the shares of the stock are sold short. View Neptune Wellness Solutions' Current Options Chain.

Who are some of Neptune Wellness Solutions' key competitors?

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Amarin (AMRN), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), Crispr Therapeutics (CRSP) and Sangamo Therapeutics (SGMO).

Who are Neptune Wellness Solutions' key executives?

Neptune Wellness Solutions' management team includes the following people:
  • Mr. James S. Hamilton, Pres, CEO & Director
  • Mr. Mario Paradis, VP & CFO
  • Mr. Marc Vaugeois, VP of Sales
  • Mr. Michel Timperio, Pres of Cannabis Bus.
  • Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus.

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Who are Neptune Wellness Solutions' major shareholders?

Neptune Wellness Solutions' stock is owned by many different institutional and retail investors. Top institutional investors include AdvisorShares Investments LLC (0.42%), Deutsche Bank AG (0.24%), White Pine Capital LLC (0.12%) and Two Sigma Investments LP (0.06%).

Which institutional investors are buying Neptune Wellness Solutions stock?

NEPT stock was purchased by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Two Sigma Investments LP, White Pine Capital LLC, and AdvisorShares Investments LLC.

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $3.15.

How big of a company is Neptune Wellness Solutions?

Neptune Wellness Solutions has a market capitalization of $299.44 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.

What is Neptune Wellness Solutions' official website?

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.